Collectively, our data suggest that LSD1 is a mediator of drug resistance in breast cancer cells and establish it as a key regulator of cancer stemness, since it affects the self-renewal and tumor-initiation capacity of bCSCs in vitro and in vivo. The gene discussed is KDM1A; the disease is cancer.